Both in Pharmaceuticals
Mereo BioPharma Group vs Akari Therapeutics plc ADR (0.01 USD)
Over the past year MREO returned −83.2% and AKTX returned −71.6%; their daily moves had a correlation of -0.01.
MREO −83.2% AKTX −71.6%Growth of $1, one year, split-adjusted
| Metric | MREO | AKTX |
|---|---|---|
| Price | $0.2979 | $7.13 |
| Market cap | $47.6M | $16.3M |
| Today | +0.95% | −6.92% |
| 1 month | −5.5% | −16.5% |
| 6 months | +21.1% | +133.0% |
| Year to date | −28.5% | −38.3% |
| 1 year | −83.5% | −72.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $7.0M |
| Dividend yield | — | — |
| Volatility (60d) | 78.8% | 117.6% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).